In situations where patients present with multiple BCCs but do not meet clinical criteria for Gorlin syndrome or other known BCC syndromes, it may be worth considering genetic screening given that MUTYH mutations are also associated with other cancers, including MAP, and if present, these mutations may warrant earlier gastrointestinal screening. Here, MUTYH is linked to nevoid basal cell carcinoma syndrome.